Search Results

There are 2440 results for: content related to: Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a

  1. Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy

    Journal of Viral Hepatitis

    Volume 16, Issue 12, December 2009, Pages: 867–875, J. E. Arends, J. Cohen Stuart, L. C. Baak, M. E. Van Der Ende, K. J. Van Erpecum, C. P. M. Simons, G. J. Boland, D. Van Baarle and A. I. M. Hoepelman

    Article first published online : 11 MAY 2009, DOI: 10.1111/j.1365-2893.2009.01143.x

  2. You have full text access to this OnlineOpen article
    Expert opinion on the treatment of patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 16, Issue 2, February 2009, Pages: 75–90, S. Zeuzem, T. Berg, B. Moeller, H. Hinrichsen, S. Mauss, H. Wedemeyer, C. Sarrazin, D. Hueppe, E. Zehnter and M. P. Manns

    Article first published online : 28 AUG 2008, DOI: 10.1111/j.1365-2893.2008.01012.x

  3. Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study

    Journal of Viral Hepatitis

    Volume 18, Issue 6, June 2011, Pages: 393–399, C. Puoti, G. Barbarini, A. Picardi, M. Romano, A. Pellicelli, A. Barlattani, F. Mecenate, R. Guarisco, O. M. Costanza, L. Spilabotti, L. Bellis, M. E. Bonaventura, O. Dell’ Unto, M. G. Elmo, A. M. Nicolini, L. Nosotti, F. Soccorsi and on behalf of the Club Epatologico Ospedaliero (Hospital Liver Club, CLEO)

    Article first published online : 8 JUN 2010, DOI: 10.1111/j.1365-2893.2010.01319.x

  4. Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study

    Journal of Viral Hepatitis

    Volume 19, Issue 6, June 2012, Pages: 423–430, P. Tangkijvanich, P. Komolmit, V. Mahachai, K. Poovorawan, S. Akkarathamrongsin and Y. Poovorawan

    Article first published online : 16 DEC 2011, DOI: 10.1111/j.1365-2893.2011.01566.x

  5. You have full text access to this OnlineOpen article
    Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

    Journal of Viral Hepatitis

    Volume 17, Issue 2, February 2010, Pages: 139–147, M. Rodriguez-Torres, M. S. Sulkowski, R. T. Chung, F. M. Hamzeh and D. M. Jensen

    Article first published online : 5 AUG 2009, DOI: 10.1111/j.1365-2893.2009.01157.x

  6. Optimal treatment duration for patients with HCV genotype 1 infection

    Journal of Viral Hepatitis

    Volume 19, Issue s1, January 2012, Pages: 7–13, P. Ferenci

    Article first published online : 10 JAN 2012, DOI: 10.1111/j.1365-2893.2011.01522.x

  7. Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study

    Journal of Viral Hepatitis

    Volume 14, Issue 10, October 2007, Pages: 704–713, C. Tural, R. Solà, R. Rubio, M. Santín, R. Planas, C. Quereda, J. Berenguer, M. Montes-Ramírez, B. Clotet and and the CORAL-1 study group

    Article first published online : 18 APR 2007, DOI: 10.1111/j.1365-2893.2007.00860.x

  8. Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 17, Issue 12, December 2010, Pages: 834–838, V. Pattullo, N. C. Ravindran, T. Mazzulli, D. K. H. Wong and E. J. Heathcote

    Article first published online : 10 NOV 2010, DOI: 10.1111/j.1365-2893.2010.01248.x

  9. Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

    Journal of Viral Hepatitis

    Volume 19, Issue 9, September 2012, Pages: 623–634, S. Pianko, S. Zeuzem, W.-L. Chuang, G. R. Foster, S. K. Sarin, R. Flisiak, C.-M. Lee, P. Andreone, T. Piratvisuth, S. Shah, A. Sood, J. George, M. Gould, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, Y. Li, M. Pang, Y. Yin, G. Feutren, I. M. Jacobson and for the B2202 Study Team

    Article first published online : 21 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01586.x

  10. Hepatitis C treatment response kinetics and impact of baseline predictors

    Journal of Viral Hepatitis

    Volume 18, Issue 6, June 2011, Pages: 400–407, M. Lindh, B. Arnholm, A. Eilard, M. Färkkilä, K. Hellstrand, M. Lagging, N. Langeland, K. Mørch, S. Nilsson, C. Pedersen, M. R. Buhl, T. Wahlberg, R. Wejstål, J. Westin and G. Norkrans

    Article first published online : 25 MAY 2010, DOI: 10.1111/j.1365-2893.2010.01323.x

  11. Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV /  HIV co-infected individuals

    Journal of Viral Hepatitis

    Volume 15, Issue 7, July 2008, Pages: 482–489, D. O. Shea, H. Tuite, G. Farrell, M. Codd, F. Mulcahy, S. Norris and C. Bergin

    Article first published online : 24 JAN 2008, DOI: 10.1111/j.1365-2893.2008.00969.x

  12. Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients

    Journal of Viral Hepatitis

    Volume 14, Issue 5, May 2007, Pages: 338–349, M.-W. Welker, W.-P. Hofmann, C. Welsch, M. Von Wagner, E. Herrmann, T. Lengauer, S. Zeuzem and C. Sarrazin

    Article first published online : 26 JUL 2006, DOI: 10.1111/j.1365-2893.2006.00798.x

  13. Peginterferon alfa-2a (40kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients

    Journal of Viral Hepatitis

    Volume 16, Issue 10, October 2009, Pages: 724–731, K. R. Reddy, D. Messinger, M. Popescu and S. J. Hadziyannis

    Article first published online : 25 MAR 2009, DOI: 10.1111/j.1365-2893.2009.01122.x

  14. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents

    Journal of Viral Hepatitis

    Volume 19, Issue 7, July 2012, Pages: 449–464, F. Poordad and D. Dieterich

    Article first published online : 7 JUN 2012, DOI: 10.1111/j.1365-2893.2012.01617.x

  15. Subtype mutations in the envelope 2 region including phosphorylation homology domain of Hepatitis C virus do not predict effectiveness of antiviral therapy

    Journal of Viral Hepatitis

    Volume 11, Issue 1, January 2004, Pages: 45–54, J. Quer, P. Murillo, M. Martell, J. Gómez, J. I. Esteban, R. Esteban and J. Guardia

    Article first published online : 23 JAN 2004, DOI: 10.1046/j.1352-0504.2003.00465.x

  16. Short-duration therapy for hepatitis C: suitable for all?

    Journal of Viral Hepatitis

    Volume 14, Issue 4, April 2007, Pages: 221–227, A. Mangia

    Article first published online : 21 DEC 2006, DOI: 10.1111/j.1365-2893.2006.00817.x

  17. Reappraisal of the importance of mutations in the NS5A-PKR-binding domain of hepatitis C-1b virus in the era of optimally individualized therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 2, February 2011, Pages: 119–128, T.-M. Chen, P.-T. Huang, C.-F. Wen, J.-N. Tung, K.-C. Chow and Y.-P. Chen

    Article first published online : 2 MAR 2010, DOI: 10.1111/j.1365-2893.2010.01287.x

  18. Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices

    Journal of Viral Hepatitis

    Volume 20, Issue 2, February 2013, Pages: 113–121, V. Di Marco, V. Calvaruso, S. Grimaudo, D. Ferraro, R. M. Pipitone, R. Di Stefano and A. Craxì

    Article first published online : 25 JUL 2012, DOI: 10.1111/j.1365-2893.2012.01637.x

  19. You have free access to this content
    Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1251–1267, F. F. POORDAD

    Article first published online : 17 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04300.x

  20. Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin

    Journal of Viral Hepatitis

    Volume 16, Issue 1, January 2009, Pages: 28–35, A. Andriulli, C. Cursaro, R. Cozzolongo, A. Iacobellis, M. R. Valvano, A. Mangia, N. Minerva, D. Bacca, M. Stanzione, A. Scuteri, G. Montalto and P. Andreone

    Article first published online : 28 AUG 2008, DOI: 10.1111/j.1365-2893.2008.01044.x